Concepedia

Ron Paquette

RP

Statistics

Publications

16

Citations

3.5K

H-Index

16

Active since

1997

Affiliations

University of California, Los Angeles(Current)

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Bristol-Myers Squibb (United States)

University of Milano-Bicocca

Ron Paquette is an author at University of California, Los Angeles specializing in medicine, hematology, and oncology.

Top concepts

Publications per year

1997–2018

16

Publications

16

Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias

Moshe Talpaz, Neil P. Shah, Hagop M. Kantarjian et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia

Kimmo Porkka, Perttu Koskenvesa, Tuija Lundán et al. · Blood · 2008 · 437 citations · Full text

An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients.

A O’Farrell, James M. Foran, Walter Fiedler et al. · PubMed · 2003 · 311 citations

Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia

Richard M. Stone, Thomas Fischer, Ron Paquette et al. · Leukemia · 2012 · 270 citations · Full text

, , +10

Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy

Hagop M. Kantarjian, Francis J. Giles, Peter L. Greenberg et al. · Blood · 2010 · 150 citations · Full text

1–5 of 16